Patents
Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
11/2010
11/25/2010US20100297169 Novel Neutralizing Immunogen (NIMIV) of Rhinovirus and its Use for Vaccine Applications
11/25/2010US20100297152 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
11/24/2010EP2252314A2 Leptin agonist and methods of use
11/24/2010CN101143890B New born calf brain active peptide, preparation method and application thereof in preparing anti-cancer medicament
11/23/2010CA2223989C Prodrugs of pharmaceuticals with improved bioavailability
11/18/2010US20100292147 Identification of the hepcidin binding site on ferroportin
11/18/2010US20100291828 Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
11/18/2010US20100291675 IgM-MEDIATED RECEPTOR CLUSTERING AND CELL MODULATION
11/18/2010US20100291147 Recombinant rsv antigens
11/18/2010US20100291134 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same
11/18/2010US20100291118 Class of Gamma Delta T Cells Activators and Use Thereof
11/18/2010US20100291086 Use of estrogen and androgen binding proteins in methods and compositions for treating gynaecological cancers
11/18/2010US20100291061 Process for making oligopeptides
11/18/2010US20100290989 Compositions affecting hyaluronic acid mediated activity
11/18/2010US20100290987 Methods and compositions for detecting and modulating o-glycosylation
11/17/2010EP2251026A1 Methods and compositions for inhibiting immunoglobulin-mediated reperfusion injury
11/15/2010CA2678775A1 Protein markers useful to differentiate immunized and infected specimens
11/11/2010WO2010129537A1 Phosphopeptides as melanoma vaccines
11/11/2010US20100286362 Mammalian MDM2 Binding Proteins and Uses Thereof
11/11/2010US20100285570 Fluoride processing method
11/11/2010US20100285497 Markers of endothelial cells and uses thereof
11/11/2010US20100285452 Molecular Markers for the Diagnosis and Treatment of Tumors
11/09/2010US7829297 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor
11/09/2010US7829064 antigen binding molecules conjugated to lipids, polymer carriers, micelles, nanoparticles or mixtures and effectors, used for therapy of diagnosis
11/04/2010US20100280177 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/04/2010US20100279918 Chimeric Constructs Between Cancer-Homing Peptides and Cell-Penetrating Peptides Coupled to Anticancer Drugs and/or Diagnostic Agent/Agents
11/04/2010US20100279378 MEK Ligands and Polynucleotides Encoding MEK Ligands
11/04/2010US20100278937 Compositions and methods to prevent and/or treat cancer with pa-card
11/04/2010US20100278857 Dendritic Cell Binding Proteins and Uses Thereof
11/04/2010US20100278807 Novel antimicrobial agents
11/03/2010EP2245061A2 Impaired wound healing compositions and treatments
11/03/2010EP1606232B1 Improved extraction process
11/03/2010EP0719273B1 Nucleotide analogs
11/02/2010US7825216 Phenylanine derivatives
11/02/2010US7825215 Substituted nucleic acid mimics
10/2010
10/28/2010WO2010123898A1 Rotamer libraries and methods of use thereof
10/28/2010WO2010122298A1 Materials based on filamentous peptide - or protein-based structures
10/28/2010US20100273725 Novel compounds useful in therapeutic and cosmetic methods
10/28/2010CA2759563A1 Rotamer libraries and methods of use thereof
10/26/2010US7820783 Contain chemically reactive carbocyanine dyes that are intramolecularly crosslinked between the 1-position and 3'-position, their bioconjugates
10/21/2010WO2010121125A1 Il-13 receptor binding peptides
10/21/2010US20100267929 PRRS Viruses, Infectious Clones, Mutants Thereof, and Methods of Use
10/21/2010US20100267649 Vascular adhesion molecules and modulation of their function
10/21/2010US20100267617 Methods and compositions for mycoplasma pneumoniae exotoxins
10/21/2010US20100267610 Polypeptide comprising a knottin protein moiety
10/21/2010US20100267608 Modifications of cupredoxin derived peptides and methods of use thereof
10/21/2010US20100267133 Acrtiib-fc polynucleotides, polypeptides, and compositions
10/21/2010US20100267019 Identification And Use Of Genes Encoding Amatoxin And Phallotoxin
10/21/2010US20100266675 Lipoproteins, lipopeptides and analogs, and methods for making and using them
10/21/2010US20100266579 Treatment of inflammatory diseases
10/21/2010US20100266507 Luminescent compounds
10/20/2010CN101868475A Food material for inhibiting bone resorption
10/14/2010US20100261889 Protein based foaming agents and methods of making thereof
10/14/2010US20100261882 Method and apparatus for assessing polypeptide aggregation
10/14/2010US20100261218 Methods for producing secondary metabolites
10/13/2010CN101861332A Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast
10/07/2010WO2010112911A2 Oligomeric or polymeric materials, processes for preparing the same, coatings and coated products comprising such materials
10/07/2010US20100256331 68Ga-Labelling of a Free and Macromolecule Conjugated Macrocyclic Chelator at Ambient Temperature
10/07/2010US20100255606 Labeled peptide having activity of binding to immunoglobulin and/or immunoglobulin complex and method of detecting or assaying immunoglobulin by using the peptide
10/07/2010US20100255488 Fret-labeled compounds and uses therefor
10/07/2010US20100254978 Antibody molecules having specificity for human ox40
10/07/2010US20100254943 Amino acid substituted molecules
10/06/2010EP2234669A1 Design and selection of medicaments that modulate the function and activity of interleukin 13
09/2010
09/30/2010US20100249386 Dinitroxide-type biradical compounds optimized for dynamic nuclear polarization (dnp)
09/30/2010US20100249369 Production and use of highly functional, highly branched or hyperbranched polylysines
09/30/2010US20100249015 Use of VEGF in the Treatment of Retarded Fetal Growth in Pregnancy
09/30/2010US20100248977 Immobilizing an Entity in a Desired Orientation on a Support Material
09/30/2010US20100247578 Carrier system for biological agents containing organosilicon compounds and uses thereof
09/30/2010US20100247529 Cooperative and dynamic assembly of affinity complexes
09/29/2010CN101848938A Modified plant defensin
09/29/2010CN101848719A Influenza inhibiting compositions and methods
09/28/2010US7803739 Substrates and assays for β-secretase
09/23/2010US20100240773 Multifunctional linkers
09/23/2010US20100240575 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same
09/23/2010US20100240574 Heyl as a Therapeutic Target and a Diagnostic Marker for Neoplasia and Uses Therefor
09/23/2010US20100240137 Derivatization-enhanced analysis of amino acids and peptides
09/23/2010US20100240088 Peptide Markers for Diagnosis of Angiogenesis
09/22/2010CN101842385A Food material for inhibiting the formation of osteoclast
09/21/2010US7799902 Receptor coupling agents and compositions thereof
09/21/2010CA2172145C Metal complexes with a charged linker
09/16/2010US20100234454 Treatment of cnidaria intoxication
09/16/2010US20100234301 Methods and Compositions for the Treatment of Gastrointestinal Disorders
09/16/2010US20100234287 Targeting Bacterial Suicide Pathways for the Development of Novel Antibiotics
09/16/2010US20100233804 Generation of pluripotent stem cells using recombinant proteins
09/16/2010US20100233781 Tubular nanostructure targeted to cell membrane
09/16/2010US20100233761 Algae biomass fractionation
09/16/2010US20100233718 Non-invasive technique for conducting skin inflammatory disease pharmaco-genomic studies and diagnoses thereof
09/16/2010US20100233678 Tunable affinity ligands for the separation and detection of target substances
09/16/2010US20100233190 Targeted polymeric prodrugs containing multifunctional linkers
09/15/2010CN101835799A Modulators of hypersensitivity reactions
09/14/2010US7795387 detecting the decreased transcription of messenger RNA transcribed from an RDCVF1 or RDCVF2 polypeptide, in the eye of a human, wherein said decreased transcription is diagnostic of such human's suffering from retinal dystrohy
09/14/2010US7795382 inclusion body tags; Expression of the fusion peptide in a host cell results in a product that is insoluble and contained within inclusion bodies in the cell and/or cell lysate
09/14/2010US7795380 Compositions and methods for nucleic acid delivery
09/14/2010US7795225 inhibitors of chondrosarcoma cell growth that are useful as anti-cancer and anti-tumor agents; inhibitors are peptides having sequences related to cleavage regions of the proenzyme forms of matrix metalloproteinases and that can inhibit the activity of matrix metalloproteinases
09/14/2010US7795042 red-emitting fluorescent rhodamine dyes; photostable; useful as molecular probes; For use in assays involving staining of cells, protein binding, and/or analysis of nucleic acids (hybridization and sequencing)
09/14/2010CA2370393C Dna sequence, and recombinant production of a gramineae allergen
09/09/2010US20100228004 Templates for nucleation and propagation of peptide secondary structure
09/09/2010US20100227794 Smart contrast agent and method for detecting transition metal ions and treating related disorders
09/09/2010US20100227042 Enzyme-Assisted De-Emulsification of Aqueous Lipid Extracts
09/09/2010US20100226987 Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 48